AbbVie and Valkai Partner to Advance AI in Clinical Development
AbbVie has partnered with Valkai to expand AI across clinical development, advancing drug development, scientific innovation, operational efficiency and patient outcomes.
AbbVie AI Infrastructure | 03/10/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy